InvestorsHub Logo
Followers 44
Posts 5657
Boards Moderated 0
Alias Born 10/28/2009

Re: Zorax post# 13414

Friday, 04/05/2024 5:53:57 AM

Friday, April 05, 2024 5:53:57 AM

Post# of 13622
Just like a redo of work already performed FDA is once again doing their substantive review. That has already been performed.

https://www.globenewswire.com/news-release/20...pdate.html

Like a learning curve FDA knows the company and the prior work performed like an audit!

12-22-21
As previously disclosed, UHP's PMA application is currently in Substantive Review by the FDA. Receipt of a PMA is a condition to the company's ability to market its HemoStyp products for human surgical procedures in the United States.
Approval within 45 days!
$5-$10++

Investors Hangout: https://investorshangout.com/post/view?id=6682448#ixzz8WW5XUAma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UEEC News